Evidence map›Paper›PMID 34933873›Full record

ArticleBMJ open diabetes research & care2021

Impact of New York State's Health Home program on access to care among patients with diabetes.

Victoria Mayer, Tod Mijanovich, Natalia Egorova, James Flory, Alvin Mushlin, Michele Calvo, Richa Deshpande, David Siscovick

Abstract read
In one paragraph

Article in BMJ open diabetes research & care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Victoria MayerDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York, USA victoria.mayer@mountsinai.org.
Tod MijanovichDepartment of Applied Statistics, Social Sciences, and Humanities, Steinhardt School, New York University, New York City, New York, USA.
Natalia EgorovaDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
James FloryEndocrinology Service, Department of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
Alvin MushlinDepartments of Population Health Sciences and Medicine, Weill Cornell Medicine, New York City, New York, USA.
Michele CalvoResearch, Evaluation & Policy, New York Academy of Medicine, New York City, New York, USA.
Richa DeshpandeDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
David SiscovickResearch, Evaluation & Policy, New York Academy of Medicine, New York City, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
NCI NIH HHS P30 CA008748NIDDK NIH HHS P30 DK111022
6 · The paper itself

Abstract

introductionAccess to care is essential for patients with diabetes to maintain health and prevent complications, and is important for health equity. New York State's Health Homes (HHs) provide care management services to Medicaid-insured patients with chronic conditions, including diabetes, and aim to improve quality of care and outcomes. There is inconsistent evidence on the impact of HHs, and care management programs more broadly, on access to care. RESEARCH DESIGN AND

methodsUsing a cohort of patients with diabetes derived from electronic health records from the INSIGHT Clinical Research Network, we analyzed Medicaid data for HH enrollees and a matched comparison group of HH non-enrollees. We estimated HH impacts on several access measures using natural experiment methods.

resultsWe identified and matched 11 646 HH enrollees; patients were largely non-Hispanic Black (29.9%) and Hispanic (48.7%), and had high rates of dual eligibility (33.0%), Supplemental Security Income disability enrollment (49.1%), and multiple comorbidities. In the 12 months following HH enrollment, HH enrollees had one more month of Medicaid coverage (p<0.001) and 4.6 more outpatient visits than expected (p<0.001, evenly distributed between primary and specialty care). There were also positive impacts on the proportions of patients with follow-up visits within 7 days (4 percentage points (pp), p<0.001) and 30 days (6pp, p<0.001) after inpatient care, and on the proportion of patients with follow-up visits within 30 days after emergency department (ED) care (4pp, p<0.001). We did not find meaningful differences in continuity of care. We found small positive impacts on the proportion of patients with an inpatient visit and the proportion with an ED visit.

conclusionsNew York State's HH program improved access to care for Medicaid recipients with diabetes. These findings have implications for New York State Medicaid as well as other providers and care management programs.

Indexed as

Diabetes MellitusInsurance, HealthHealth Services AccessibilityHumansMedicaidNew YorkUnited Statesdiabetes mellitusimpactmedicaidtype 2

Identifiers

PMID34933873
PMCPMC8679110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.